SCHEMBL8688775

SCHEMBL8688775

CCCCCNCCc1ccccc1-c1c[nH]nn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.46
▸ HTR1A P08908 2/20 0.37
▸ HTR1D P28221 2/20 0.37
▸ HTR1B P28222 2/20 0.37
▸ MPO P05164 1/20 0.36
▸ HTR2A P28223 2/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ HTR5A P47898 1/20 0.35
▸ CHRM2 P08172 8/20 0.34
▸ GRIN1 Q05586 4/20 0.34
▸ GRIN2A Q12879 4/20 0.34
▸ BCHE P06276 4/20 0.34
▸ ACHE P22303 4/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CHRM4 P08173 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CHRM5 P08912 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28169397 0.85 NR1H2 (0.36) CYP3A4CYP2D6
Formaldehyde SCHEMBL28673465 0.80 CHRM2 (0.38) SIGMAR1CHRM2TP53
SCHEMBL8692355 0.80 SIGMAR1 (0.46) SIGMAR1HTR1AHTR1DHTR1BMPO
Formaldehyde SCHEMBL28676768 0.77 KDM4E (0.38) SIGMAR1HTR1AHTR1DHTR1BHTR2A
SCHEMBL8689398 0.77 SIGMAR1 (0.46) SIGMAR1HTR1AHTR1DHTR1BMPO
SCHEMBL8688772 0.76 SIGMAR1 (0.51) SIGMAR1CYP2D6SLC2A1
SCHEMBL11194759 0.76 TRPA1 (0.38) CYP2D6
SCHEMBL11351465 0.70 ALDH1A1 (0.33) TSHR
SCHEMBL5426875 0.68 SIGMAR1 (0.44) SIGMAR1HTR1AHTR1DHTR1BMPO
SCHEMBL3008829 0.68 SIGMAR1 (0.59) SIGMAR1HTR2ACHRM2GRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807860-A ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE INHIBITORS; HYPERLIPEMIA, ATHEROSCLEROSIS; ANTICHOLESTEROL AGENTS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-09-15 — — US disclosed
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 — — EP disclosed
Send feedback